Viking Fund Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.14M | Hold |
338,000
| – | – | 0.73% | 52 |
|
|
2026
Q1 | $9.49M | Buy |
338,000
+2,500
| +0.7% | +$66.6K | 0.97% | 38 |
|
|
2025
Q4 | $8.35M | Buy |
335,500
+1,500
| +0.4% | +$37.8K | 0.97% | 40 |
|
|
2025
Q3 | $8.51M | Buy |
334,000
+30,000
| +10% | +$740K | 1.03% | 33 |
|
|
2025
Q2 | $7.37M | Sell |
304,000
-80,000
| -21% | -$1.87M | 1.01% | 32 |
|
|
2025
Q1 | $9.73M | Hold |
384,000
| – | – | 1.4% | 20 |
|
|
2024
Q4 | $10.2M | Buy |
384,000
+40,000
| +12% | +$1.08M | 1.59% | 15 |
|
|
2024
Q3 | $9.96M | Buy |
344,000
+58,000
| +20% | +$1.69M | 1.62% | 17 |
|
|
2024
Q2 | $8M | Buy |
286,000
+11,000
| +4% | +$303K | 1.43% | 26 |
|
|
2024
Q1 | $7.63M | Buy |
275,000
+59,700
| +28% | +$1.66M | 1.38% | 25 |
|
|
2023
Q4 | $6.2M | Buy |
215,300
+400
| +0.2% | +$12.1K | 1.21% | 27 |
|
|
2023
Q3 | $7.13M | Buy |
214,900
+34,300
| +19% | +$1.21M | 1.44% | 22 |
|
|
2023
Q2 | $6.62M | Buy |
180,600
+16,600
| +10% | +$646K | 1.25% | 25 |
|
|
2023
Q1 | $6.69M | Buy |
164,000
+10,000
| +6% | +$432K | 1.29% | 22 |
|
|
2022
Q4 | $7.89M | Hold |
154,000
| – | – | 1.57% | 16 |
|
|
2022
Q3 | $6.74M | Buy |
154,000
+6,000
| +4% | +$292K | 1.59% | 14 |
|
|
2022
Q2 | $7.76M | Sell |
148,000
-15,000
| -9% | -$764K | 1.8% | 12 |
|
|
2022
Q1 | $8.44M | Buy |
163,000
+5,000
| +3% | +$259K | 1.92% | 10 |
|
|
2021
Q4 | $9.33M | Hold |
158,000
| – | – | 2.46% | 6 |
|
|
2021
Q3 | $6.8M | Buy |
158,000
+10,000
| +7% | +$443K | 1.97% | 10 |
|
|
2021
Q2 | $5.8M | Hold |
148,000
| – | – | 1.65% | 17 |
|
|
2021
Q1 | $5.36M | Hold |
148,000
| – | – | 1.6% | 15 |
|
|
2020
Q4 | $5.45M | Sell |
148,000
-7,992
| -5% | -$293K | 1.75% | 16 |
|
|
2020
Q3 | $5.43M | Hold |
155,992
| – | – | 2.02% | 12 |
|
|
2020
Q2 | $4.84M | Buy |
155,992
+5,270
| +3% | +$179K | 1.79% | 13 |
|
|
2020
Q1 | $4.67M | Buy |
150,722
+76,942
| +104% | +$2.62M | 2.05% | 10 |
|
|
2019
Q4 | $2.74M | Buy |
73,780
+18,972
| +35% | +$676K | 0.77% | 48 |
|
|
2019
Q3 | $1.87M | Buy |
54,808
+2,108
| +4% | +$76.7K | 0.53% | 56 |
|
|
2019
Q2 | $2.17M | Buy |
52,700
+3,162
| +6% | +$126K | 0.58% | 60 |
|
|
2019
Q1 | $2M | Hold |
49,538
| – | – | 0.5% | 61 |
|
|
2018
Q4 | $2.05M | Sell |
49,538
-25,296
| -34% | -$1.05M | 0.57% | 58 |
|
|
2018
Q3 | $3.13M | Sell |
74,834
-49,538
| -40% | -$1.91M | 0.64% | 52 |
|
|
2018
Q2 | $4.28M | Sell |
124,372
-27,404
| -18% | -$936K | 0.82% | 41 |
|
|
2018
Q1 | $5.11M | Hold |
151,776
| – | – | 0.97% | 38 |
|
|
2017
Q4 | $5.22M | Hold |
151,776
| – | – | 0.85% | 40 |
|
|
2017
Q3 | $5.14M | Sell |
151,776
-4,216
| -3% | -$136K | 0.82% | 38 |
|
|
2017
Q2 | $4.97M | Buy |
155,992
+29,512
| +23% | +$931K | 0.76% | 41 |
|
|
2017
Q1 | $4.11M | Buy |
126,480
+7,378
| +6% | +$233K | 0.55% | 52 |
|
|
2016
Q4 | $3.67M | Buy |
+119,102
| New | +$3.64M | 0.46% | 53 |
|
Other funds holding PFE
Viking Fund Management's PFE Position: Q2 2026 in Review
Viking Fund Management held its Pfizer (PFE) position steady in Q2 2026 at 338,000 shares worth $8.14M. The position accounts for 0.73% of the portfolio, ranked #52.
Viking Fund Management first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $10.2M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Viking Fund Management held 338,000 shares of Pfizer worth $8.14M as of Q2 2026.
- Viking Fund Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.73% of Viking Fund Management's portfolio in Q2 2026, its #52 holding.
- Viking Fund Management first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
- Viking Fund Management's Pfizer position peaked at $10.2M in Q4 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.